Loading clinical trials...
Loading clinical trials...
The primary requirement of the implantable cardioverter defibrillator (ICD) is to preserve life by terminating life-threatening arrhythmias (VT/VF). The treatment options vary in terms of techniques a...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
MicroPort CRM
NCT05373940 · Heart Failure, Primary Prevention of Sudden Cardiac Death, and more
NCT06378996 · Mitral Valve Prolapse, Ventricular Arrythmia
NCT07196397 · Vasovagal Syndrome VVS, Cardioinhibitory Carotid Sinus Syndrome CSS, and more
NCT06964464 · Heart Failure With Reduced Ejection Fraction (HFrEF), Sudden Cardiac Death, and more
NCT06889662 · Myocarditis, Ventricular Arrythmia
LKH Feldkirch
Feldkirchen bei Mattighofen
LKH Innsbruck
Innsbruck
Kepler Universitatsklinikum GmbH
Linz
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions